Daewon Pharmaceutical Co Ltd
KRX:003220

Watchlist Manager
Daewon Pharmaceutical Co Ltd Logo
Daewon Pharmaceutical Co Ltd
KRX:003220
Watchlist
Price: 12 190 KRW 0.16%
Market Cap: 273.4B KRW

Intrinsic Value

The intrinsic value of one Daewon Pharmaceutical Co Ltd stock under the Base Case scenario is 23 495.78 KRW. Compared to the current market price of 12 190 KRW, Daewon Pharmaceutical Co Ltd is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
23 495.78 KRW
Undervaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Daewon Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Daewon Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Daewon Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Daewon Pharmaceutical Co Ltd.

Explain Valuation
Compare Daewon Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Daewon Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Daewon Pharmaceutical Co Ltd

Current Assets 247.3B
Cash & Short-Term Investments 42.8B
Receivables 71.2B
Other Current Assets 133.3B
Non-Current Assets 334.1B
Long-Term Investments 51.4B
PP&E 215.4B
Intangibles 55.2B
Other Non-Current Assets 12B
Current Liabilities 205.8B
Accounts Payable 28.5B
Accrued Liabilities 9.9B
Short-Term Debt 78B
Other Current Liabilities 89.3B
Non-Current Liabilities 103.9B
Long-Term Debt 60.7B
Other Non-Current Liabilities 43.2B
Efficiency

Free Cash Flow Analysis
Daewon Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Daewon Pharmaceutical Co Ltd

Revenue
603.6B KRW
Cost of Revenue
-322.5B KRW
Gross Profit
281.1B KRW
Operating Expenses
-258.5B KRW
Operating Income
22.6B KRW
Other Expenses
-14.4B KRW
Net Income
8.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Daewon Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
44/100
Profitability
Score

Daewon Pharmaceutical Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Daewon Pharmaceutical Co Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
44/100
Solvency
Score

Daewon Pharmaceutical Co Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Daewon Pharmaceutical Co Ltd

Wall Street analysts forecast Daewon Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Daewon Pharmaceutical Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

Lowest
Price Target
16 160 KRW
33% Upside
Average
Price Target
16 320 KRW
34% Upside
Highest
Price Target
16 800 KRW
38% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Daewon Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Daewon Pharmaceutical Co Ltd stock?

The intrinsic value of one Daewon Pharmaceutical Co Ltd stock under the Base Case scenario is 23 495.78 KRW.

Is Daewon Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12 190 KRW, Daewon Pharmaceutical Co Ltd is Undervalued by 48%.

Back to Top